Directory
>
Holger Thurm
Holger Thurm
Resident in OB/GYN | Pfizer
California, San Diego, United States
Holger Thurm
Summary
Holger Thurm is an accomplished Executive Director at Pfizer, specializing in oncology drug development with over 20 years in the healthcare sector. He holds both an MD and an MS in molecular medicine and biology, underscoring his strong academic foundation. Holger has successfully led the clinical development of several groundbreaking cancer therapies, including Lorbrena/Lorviqua®, Xalkori®, and Gliolan®. His extensive experience includes roles as a Global Clinical Lead and Senior Medical Director, where he has demonstrated his ability to navigate complex regulatory environments. Holger is passionate about improving patient outcomes in oncology and is known for building high-performing teams in cross-functional settings. His strategic mindset and innovative approach have been pivotal in establishing partnerships that drive success in drug development. Fluent in both English and German, he brings a global perspective to his work, enhancing collaboration across diverse teams.
Holger Thurm
Work Experience
Executive Director at
Pfizer
July 2021 - Present
Holger Thurm
Education
Freie Universität Berlin, Doctor of Medicine - MD
January 1993 - January 1999
Freie Universität Berlin, Master of Science - MS
January 1991 - January 1996
Frequently Asked Questions about Holger Thurm
What is Holger Thurm email address?
Holger Thurm's primary email address is ************@pfizer.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Holger Thurm work for?
Holger Thurm is a Resident in OB/GYN at Pfizer.
Where Holger Thurm graduated from?
Holger Thurm holds a degree in null from Freie Universität Berlin.
How can I directly contact Holger Thurm?
To contact Holger Thurm directly, you can use the email address ************@pfizer.com. Complete contact information is available upon registration with Muraena.
Is Holger Thurm an immigrant?
Yes, Holger Thurm is an immigrant and currently based in United States
Who is Holger Thurm?
Holger Thurm is an accomplished Executive Director at Pfizer, specializing in oncology drug development with over 20 years in the healthcare sector. He holds both an MD and an MS in molecular medicine and biology, underscoring his strong academic foundation. Holger has successfully led the clinical development of several groundbreaking cancer therapies, including Lorbrena/Lorviqua®, Xalkori®, and Gliolan®. His extensive experience includes roles as a Global Clinical Lead and Senior Medical Director, where he has demonstrated his ability to navigate complex regulatory environments. Holger is passionate about improving patient outcomes in oncology and is known for building high-performing teams in cross-functional settings. His strategic mindset and innovative approach have been pivotal in establishing partnerships that drive success in drug development. Fluent in both English and German, he brings a global perspective to his work, enhancing collaboration across diverse teams.
Holger`s contact details
************@pfizer.com
Colleagues
Executive Director, US Regulatory
Senior Scientist
Surveillance Epidemiologist
Customer Logistics Manager
Chief Counsel - Japan
Surgical Residency
Operations Research Analyst
Due Diligence | Private Equity Practice
Head of Industrial Technology
Audit Manager/Senior